MeSH term
Frequency | Condition_Probility | Adult | 5 | 0.0 |
Comparative Study | 5 | 0.0 |
Humans | 44 | 0.0 |
DNA Mutational Analysis | 5 | 0.0 |
Exons | 3 | 0.0 |
Female | 10 | 0.0 |
Holoprosencephaly/*genetics | 5 | 27.0 |
Homeodomain Proteins/*genetics | 6 | 1.0 |
Introns | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Pregnancy | 3 | 0.0 |
Repressor Proteins/*genetics | 5 | 1.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Transforming Growth Factor beta/metabolism | 3 | 1.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Child, Preschool | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Male | 9 | 0.0 |
Middle Aged | 3 | 0.0 |
Mutation | 3 | 0.0 |
Animals | 22 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Homeodomain Proteins/genetics/*metabolism | 4 | 2.0 |
Repressor Proteins/genetics/*metabolism | 4 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
*Transcription, Genetic | 4 | 0.0 |
COS Cells | 6 | 0.0 |
Cercopithecus aethiops | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 3 | 0.0 |
Trans-Activators/genetics/*metabolism | 3 | 0.0 |
Transcription Factors/*metabolism | 4 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Transforming Growth Factor beta/pharmacology | 3 | 0.0 |
Base Sequence | 10 | 0.0 |
Holoprosencephaly/epidemiology/*genetics | 2 | 100.0 |
Infant | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Trans-Activators/*genetics | 3 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
Cell Line | 3 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Phosphorylation | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
Repressor Proteins/*metabolism | 2 | 1.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Signal Transduction | 5 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
*Repressor Proteins | 4 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Transfection | 4 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Homeodomain Proteins/*metabolism | 2 | 1.0 |
Kinetics | 2 | 0.0 |
Transforming Growth Factor beta/*pharmacology | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Mice | 7 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
*Genes, Homeobox | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Chromosomes, Human, Pair 18/genetics | 2 | 4.0 |
Exons/genetics | 2 | 0.0 |
Gene Expression Regulation/genetics | 2 | 1.0 |
Binding, Competitive | 2 | 0.0 |
Homeodomain Proteins/chemistry/*genetics | 2 | 8.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
Transcription Factors/physiology | 2 | 0.0 |
Picibanil/*therapeutic use | 3 | 20.0 |
Rats | 3 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Molecular Weight | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Transcription Factors/chemistry/genetics/*metabolism | 2 | 1.0 |
Evolution, Molecular | 2 | 0.0 |
Genes, Homeobox/*genetics | 2 | 3.0 |
Transforming Growth Factor beta/*genetics | 2 | 2.0 |
Genes, Homeobox | 2 | 2.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Aged | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Picibanil/*pharmacology | 2 | 11.0 |
